In a study by Macia et al.[6], the expression of Spry1 reportedly restrained the proliferation of the human medullary thyroid carcinoma cell line TT in vitro and significantly inhibited tumor growth in the murine xenografts. This evidence concerns the gene SPRY1 and neoplasm.